0001415889-24-007437.txt : 20240308
0001415889-24-007437.hdr.sgml : 20240308
20240308184746
ACCESSION NUMBER: 0001415889-24-007437
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240306
FILED AS OF DATE: 20240308
DATE AS OF CHANGE: 20240308
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jiang Wenbin
CENTRAL INDEX KEY: 0001872873
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40632
FILM NUMBER: 24736125
MAIL ADDRESS:
STREET 1: C/O CYTEK BIOSCIENCES, INC.
STREET 2: 46107 LANDING PARKWAY
CITY: FREMONT
STATE: CA
ZIP: 94538
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cytek Biosciences, Inc.
CENTRAL INDEX KEY: 0001831915
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 472547526
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 47215 LAKEVIEW BOULEVARD
CITY: FREMONT
STATE: CA
ZIP: 94538
BUSINESS PHONE: (877) 922-9835
MAIL ADDRESS:
STREET 1: 47215 LAKEVIEW BOULEVARD
CITY: FREMONT
STATE: CA
ZIP: 94538
FORMER COMPANY:
FORMER CONFORMED NAME: Cytek BioSciences, Inc.
DATE OF NAME CHANGE: 20201110
4
1
form4-03082024_110341.xml
X0508
4
2024-03-06
0001831915
Cytek Biosciences, Inc.
CTKB
0001872873
Jiang Wenbin
C/O CYTEK BIOSCIENCES, INC.
47215 LAKEVIEW BOULEVARD
FREMONT
CA
94538
true
true
false
false
PRESIDENT AND CEO
0
Employee Stock Option (right to buy)
7.07
2024-03-06
4
A
0
526315
0
A
2034-03-06
Common Stock
526315
526315
D
Restricted Stock Units
2024-03-06
4
A
0
353606
0
A
Common Stock
353606
353606
D
The shares subject to the option shall vest over 4 years with 1/48 of the total shares underlying the option vesting on April 6, 2024 and each month thereafter.
Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2024 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2024 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2024 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2025 and each March 10 thereafter.
/s/ Valerie Barnett, Attorney-in-Fact
2024-03-08